{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:57:43Z","timestamp":1790204263765,"version":"4.1.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.jaad.2016.06.014","type":"journal-article","created":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T12:32:44Z","timestamp":1469536364000},"page":"798-805.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["From the Medical Board of the National Psoriasis Foundation: Perioperative management of systemic immunomodulatory agents in patients with psoriasis and psoriatic arthritis"],"prefix":"10.1016","volume":"75","author":[{"given":"Young M.","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Debbaneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M.","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul S.","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abby S.","family":"Van Voorhees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April W.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jashin J.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jaad.2016.06.014_bib1","first-page":"12","article-title":"Immune system and surgical site infection","volume":"13 Spec No 1","author":"Esposito","year":"2001","journal-title":"J\u00a0Chemother"},{"issue":"11","key":"10.1016\/j.jaad.2016.06.014_bib2","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1592\/phco.2005.25.11.1566","article-title":"Effects of perioperative antiinflammatory and immunomodulating therapy on surgical wound healing","volume":"25","author":"Busti","year":"2005","journal-title":"Pharmacotherapy"},{"issue":"7183","key":"10.1016\/j.jaad.2016.06.014_bib3","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1136\/bmj.318.7183.593","article-title":"Developing guidelines","volume":"318","author":"Shekelle","year":"1999","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.jaad.2016.06.014_bib4","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jaad.2009.04.039","article-title":"Perioperative use of anti-tumor necrosis factor-alfa agents","volume":"62","author":"Reinstadler","year":"2010","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 1","key":"10.1016\/j.jaad.2016.06.014_bib5","first-page":"S24","article-title":"Management of patients with psoriasis treated with biologic drugs needing a surgical treatment","volume":"75","author":"Fabiano","year":"2014","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.jaad.2016.06.014_bib6","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/jdv.12997","article-title":"The risk of post-operative complications in psoriasis and psoriatic arthritis patients on biologic therapy undergoing surgical procedures","volume":"30","author":"Bakkour","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.jaad.2016.06.014_bib7","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/art.21841","article-title":"Tumor necrosis factor\u00a0inhibitor therapy and risk of serious postoperative orthopedic infection in rheumatoid arthritis","volume":"55","author":"Giles","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.jaad.2016.06.014_bib8","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/rheumatology\/kep376","article-title":"Complications and\u00a0features after joint surgery in rheumatoid arthritis patients treated with tumor necrosis factor-\u03b1 blockers: perioperative interruption of tumor necrosis factor-\u03b1 blockers decreases complications?","volume":"49","author":"Kawakami","year":"2010","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.jaad.2016.06.014_bib9","first-page":"689","article-title":"Risk factors for surgical site infections and other complications in elective surgery in patients with rheumatoid arthritis with special attention for anti-tumor necrosis factor: a large retrospective study","volume":"34","author":"den Broeder","year":"2007","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.jaad.2016.06.014_bib10","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3109\/s10165-011-0423-x","article-title":"Prosthetic joint infection after total hip or knee arthroplasty in rheumatoid arthritis patients treated with nonbiologic and biologic disease-modifying antirheumatic drugs","volume":"21","author":"Momohara","year":"2011","journal-title":"Mod Rheumatol"},{"issue":"4","key":"10.1016\/j.jaad.2016.06.014_bib11","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1136\/ard.2004.028365","article-title":"Tumor necrosis factor \u03b1 antagonists and early postoperative complications in patients with inflammatory joint disease undergoing elective orthopedic surgery","volume":"64","author":"Talwalkar","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.jaad.2016.06.014_bib12","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1136\/ard.2005.037762","article-title":"Surgery in patients\u00a0receiving anti-tumor necrosis factor \u03b1 treatment in rheumatoid arthritis: an observational study on 50 surgical procedures","volume":"64","author":"Wendling","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.jaad.2016.06.014_bib13","first-page":"430","article-title":"Complication rates of 127 surgical procedures performed in rheumatic patients receiving tumor necrosis factor alpha blockers","volume":"25","author":"Ruyssen-Wiltrand","year":"2007","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"10.1016\/j.jaad.2016.06.014_bib14","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s10067-009-1346-1","article-title":"Influences of anti-tumor necrosis factor agents on postoperative recovery in patients with rheumatoid arthritis","volume":"29","author":"Hirano","year":"2010","journal-title":"Clin Rheumatol"},{"issue":"6","key":"10.1016\/j.jaad.2016.06.014_bib15","doi-asserted-by":"crossref","first-page":"844","DOI":"10.3109\/s10165-012-0612-2","article-title":"Perioperative complications in elective surgery in patients with rheumatoid arthritis treated with biologics","volume":"22","author":"Kubota","year":"2012","journal-title":"Mod Rheumatol"},{"issue":"5","key":"10.1016\/j.jaad.2016.06.014_bib16","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/107110070402500510","article-title":"Infectious and healing complications after elective orthopedic foot and ankle surgery during tumor necrosis factor-alpha inhibition therapy","volume":"25","author":"Bibbo","year":"2004","journal-title":"Foot Ankle Int"},{"issue":"1","key":"10.1016\/j.jaad.2016.06.014_bib17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1756-185X.2010.01579.x","article-title":"Clinical factors related to the\u00a0efficacy and complications of orthopedic surgery for rheumatoid arthritis with infliximab","volume":"14","author":"Hayata","year":"2011","journal-title":"Int J Rheum Dis"},{"issue":"5","key":"10.1016\/j.jaad.2016.06.014_bib18","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3899\/jrheum.121171","article-title":"Patterns and associated risk of perioperative use of anti-tumor necrosis factor in patients with rheumatoid arthritis undergoing total knee replacement","volume":"40","author":"Johnson","year":"2013","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.jaad.2016.06.014_bib19","first-page":"1129","article-title":"Influence of methotrexate on the frequency of postoperative infectious complications in patients with rheumatoid arthritis","volume":"20","author":"Sany","year":"1993","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.jaad.2016.06.014_bib20","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/ard.60.3.214","article-title":"Methotrexate and\u00a0early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopedic surgery","volume":"60","author":"Grennan","year":"2001","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.jaad.2016.06.014_bib21","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/art.1780340204","article-title":"Local infectious\u00a0complications following large joint replacement in rheumatoid arthritis patients treated with methotrexate versus those not treated with methotrexate","volume":"34","author":"Perhala","year":"1991","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.jaad.2016.06.014_bib22","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.3928\/0147-7447-19931101-10","article-title":"Postoperative results of rheumatoid arthritis patients on methotrexate at the time of reconstructive surgery of the hand","volume":"16","author":"Kasdan","year":"1993","journal-title":"Orthopedics"},{"issue":"3","key":"10.1016\/j.jaad.2016.06.014_bib23","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1053\/jhsu.2002.32958","article-title":"Influence of steroids and methotrexate on wound complications after elective rheumatoid hand and wrist surgery","volume":"27","author":"Jain","year":"2002","journal-title":"J Hand Surg Am"},{"issue":"1","key":"10.1016\/j.jaad.2016.06.014_bib24","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3109\/s10165-005-0444-4","article-title":"Lack of increase in postoperative complications with low-dose methotrexate therapy in patients with rheumatoid arthritis undergoing elective orthopedic surgery","volume":"16","author":"Murata","year":"2006","journal-title":"Mod Rheumatol"},{"issue":"6","key":"10.1016\/j.jaad.2016.06.014_bib25","first-page":"823","article-title":"Methotrexate and post operative complications in patients with rheumatoid arthritis undergoing elective orthopedic surgery \u2013 a ten year follow-up","volume":"77","author":"Sreekumar","year":"2011","journal-title":"Acta Orthop Belg"},{"issue":"7","key":"10.1016\/j.jaad.2016.06.014_bib26","first-page":"984","article-title":"Should methotrexate be discontinued before elective orthopedic surgery in patients with rheumatoid arthritis?","volume":"18","author":"Bridges","year":"1991","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.jaad.2016.06.014_bib27","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3928\/0147-7447-19960301-09","article-title":"Postoperative joint infections in rheumatoid arthritis patients on methotrexate therapy","volume":"19","author":"Carpenter","year":"1996","journal-title":"Orthopedics"},{"issue":"4","key":"10.1016\/j.jaad.2016.06.014_bib28","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2310\/7750.2011.10066","article-title":"Canadian Psoriasis Guidelines Committee. Canadian guidelines for the management of plaque psoriasis: overview","volume":"15","author":"Papp","year":"2011","journal-title":"J Cutan Med Surg"},{"issue":"1","key":"10.1016\/j.jaad.2016.06.014_bib29","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1001\/archdermatol.2011.1410","article-title":"Consensus guidelines for the management of plaque psoriasis","volume":"148","author":"Hsu","year":"2012","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2016.06.014_bib30","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/art.23721","article-title":"American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis","volume":"59","author":"Saag","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2016.06.014_bib31","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3109\/s10165-007-0626-3","article-title":"Update on the\u00a0Japanese guidelines for the use of infliximab and etanercept in rheumatoid arthritis","volume":"17","author":"Koike","year":"2007","journal-title":"Mod Rheumatol"},{"issue":"Suppl 1","key":"10.1016\/j.jaad.2016.06.014_bib32","first-page":"S1","article-title":"Anti TNF alpha therapy and safety monitoring. Clinical tool guide elaborated by the Club Rhumatismes et Inflammation (CRI), section of the French Society of Rheumatology","volume":"72","author":"Pham","year":"2005","journal-title":"Joint Bone Spine"},{"issue":"11","key":"10.1016\/j.jaad.2016.06.014_bib33","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1093\/rheumatology\/keq249a","article-title":"BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies","volume":"49","author":"Ding","year":"2010","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.jaad.2016.06.014_bib34","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1365-2133.2009.09505.x","article-title":"British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009","volume":"161","author":"Smith","year":"2009","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2016.06.014_bib35","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.clinthera.2011.11.015","article-title":"Golimumab pharmocokinetics after repeated subcutaneous and intravenous administrations in patients with rheumatoid arthritis and the effect of concomitant methotrexate: an open-label, randomized study","volume":"34","author":"Zhuang","year":"2012","journal-title":"Clin Ther"},{"issue":"Suppl 1","key":"10.1016\/j.jaad.2016.06.014_bib36","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40259-013-0064-z","article-title":"Pegylation of biological molecules and potential benefits: pharmacological properties of certolizumab pegol","volume":"28","author":"Pasut","year":"2014","journal-title":"BioDrugs"},{"issue":"12","key":"10.1016\/j.jaad.2016.06.014_bib37","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1111\/1346-8138.12668","article-title":"Secukinumab efficacy and safety in Japanese patients with moderate-to-severe plaque psoriasis: subanalysis from ERASURE, a randomized, placebo-controlled, phase-3 study","volume":"41","author":"Ohtsuki","year":"2014","journal-title":"J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2016.06.014_bib38","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1124\/pr.57.2.3","article-title":"Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis","volume":"57","author":"Cronstein","year":"2005","journal-title":"Pharmacol Rev"},{"issue":"2","key":"10.1016\/j.jaad.2016.06.014_bib39","doi-asserted-by":"crossref","first-page":"374","DOI":"10.2215\/CJN.03791106","article-title":"Therapeutic monitoring of calcineurin inhibitors for the nephrologist","volume":"2","author":"Schiff","year":"2007","journal-title":"Am Soc Nephrol"},{"issue":"9","key":"10.1016\/j.jaad.2016.06.014_bib40","doi-asserted-by":"crossref","first-page":"957","DOI":"10.2217\/imt.15.63","article-title":"Targeting IL-17 with ixekizumab in patients with psoriasis","volume":"7","author":"Dyring-Andersen","year":"2015","journal-title":"Immunotherapy"},{"issue":"8","key":"10.1016\/j.jaad.2016.06.014_bib41","doi-asserted-by":"crossref","first-page":"748","DOI":"10.4065\/mcp.2011.0074","article-title":"Inflammatory bowel disease: perioperative pharmacological considerations","volume":"86","author":"Kumar","year":"2011","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"10.1016\/j.jaad.2016.06.014_bib42","first-page":"856","article-title":"A systematic review on the optimum management of the use of methotrexate in rheumatoid arthritis patients in the perioperative period to minimize perioperative morbidity and maintain disease control","volume":"27","author":"Loza","year":"2009","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"10.1016\/j.jaad.2016.06.014_bib43","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/gutjnl-2011-301495","article-title":"Preoperative biological therapy and short-term outcomes of abdominal surgery in patients with inflammatory bowel disease","volume":"62","author":"Waterman","year":"2013","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.jaad.2016.06.014_bib44","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jamcollsurg.2006.12.044","article-title":"Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis","volume":"204","author":"Selvasekar","year":"2007","journal-title":"J Am Coll Surg"},{"issue":"10","key":"10.1016\/j.jaad.2016.06.014_bib45","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1007\/s11605-008-0646-0","article-title":"Use of infliximab within 3 months of ileocolonic resection is associated with adverse postoperative outcomes in Crohn's patients","volume":"12","author":"Appau","year":"2008","journal-title":"J Gastrointest Surg"},{"issue":"8","key":"10.1016\/j.jaad.2016.06.014_bib46","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1007\/s10350-008-9364-7","article-title":"Infliximab in ulcerative colitis is associated with an increased risk of postoperative complications after restorative proctocolectomy","volume":"51","author":"Mor","year":"2008","journal-title":"Dis Colon Rectum"},{"issue":"2","key":"10.1016\/j.jaad.2016.06.014_bib47","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.crohns.2012.03.013","article-title":"Previous infliximab therapy and postoperative complications after proctocolectomy with ileum pouch anal anastomosis","volume":"7","author":"Eshuis","year":"2013","journal-title":"J Crohns Colitis"},{"issue":"4","key":"10.1016\/j.jaad.2016.06.014_bib48","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/ajg.2012.464","article-title":"Anti-tumor necrosis factor therapy is associated with infections after abdominal surgery in Crohn's disease patients","volume":"108","author":"Syed","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.jaad.2016.06.014_bib49","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/j.1572-0241.2004.04148.x","article-title":"Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy","volume":"99","author":"Colombel","year":"2004","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"10.1016\/j.jaad.2016.06.014_bib50","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1007\/s10350-007-9077-3","article-title":"Does infliximab infusion impact results of operative treatment for Crohn's perianal fistulas?","volume":"50","author":"Gaertner","year":"2007","journal-title":"Dis Colon Rectum"},{"issue":"7","key":"10.1016\/j.jaad.2016.06.014_bib51","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1365-2036.2004.01904.x","article-title":"The risk of post-operative complications associated with infliximab therapy for Crohn's disease: a controlled cohort study","volume":"19","author":"Marchal","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.jaad.2016.06.014_bib52","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1007\/s10350-007-9008-3","article-title":"Does infliximab influence surgical morbidity of ileal pouch-anal anastamosis in patients with ulcerative colitis?","volume":"50","author":"Schluender","year":"2007","journal-title":"Dis Colon Rectum"},{"issue":"10","key":"10.1016\/j.jaad.2016.06.014_bib53","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1007\/s11605-008-0630-8","article-title":"Perioperative treatment with infliximab in patients with Crohn's disease and ulcerative colitis is not associated with an increased rate of postoperative complications","volume":"12","author":"Kunitake","year":"2008","journal-title":"J Gastrointest Surg"},{"issue":"7","key":"10.1016\/j.jaad.2016.06.014_bib54","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/ibd.20863","article-title":"Corticosteroids but not infliximab increase short-term postoperative infectious complications in patients with ulcerative colitis","volume":"15","author":"Ferrante","year":"2009","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"10.1016\/j.jaad.2016.06.014_bib55","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1007\/s00464-009-0861-0","article-title":"Preoperative infliximab treatment and postoperative complications after laparoscopic restorative proctocolectomy with ileal pouch-anal anastomosis: a case-matched study","volume":"24","author":"Coquet-Reinier","year":"2010","journal-title":"Surg Endosc"},{"issue":"12","key":"10.1016\/j.jaad.2016.06.014_bib56","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s11605-010-1341-5","article-title":"Perioperative anti-tumor necrosis factor therapy does not increase the rate of early postoperative complications in Crohn's disease","volume":"14","author":"Nasir","year":"2010","journal-title":"J Gastrointest Surg"},{"issue":"11","key":"10.1016\/j.jaad.2016.06.014_bib57","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1111\/j.1463-1318.2010.02469.x","article-title":"Surgical resection in Crohn's disease: is immunosuppressive medication associated with higher postoperative infection rates?","volume":"13","author":"Canedo","year":"2011","journal-title":"Colorectal Dis"},{"issue":"3","key":"10.1016\/j.jaad.2016.06.014_bib58","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.crohns.2011.08.014","article-title":"Infliximab and complications after colectomy in patients with ulcerative colitis","volume":"6","author":"Bregnbak","year":"2012","journal-title":"J Crohns Colitis"},{"issue":"7","key":"10.1016\/j.jaad.2016.06.014_bib59","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/ibd.21860","article-title":"Infliximab does not affect postoperative complication rates in Crohn's patients undergoing abdominal surgery","volume":"18","author":"Kasparek","year":"2012","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"10.1016\/j.jaad.2016.06.014_bib60","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.amjsurg.2011.11.001","article-title":"Outcomes of ileocolonic resection and right hemicolectomies for Crohn's patients in comparison with non-Crohn's patients and the impact of perioperative immunosuppressive therapy with biologics and steroids on inpatient complications","volume":"203","author":"Mascarenhas","year":"2012","journal-title":"Am J Surg"},{"issue":"11","key":"10.1016\/j.jaad.2016.06.014_bib61","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/j.1365-2036.2012.05099.x","article-title":"Pre-operative use of anti-TNF-\u03b1 agents and the risk of post-operative complications in patients with ulcerative colitis - a nationwide cohort study","volume":"35","author":"N\u00f8rg\u00e5rd","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.jaad.2016.06.014_bib62","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/BF02049146","article-title":"Morbidity of subtotal colectomy in patients with severe ulcerative colitis unresponsive to cyclosporin","volume":"38","author":"Fleshner","year":"1995","journal-title":"Dis Colon Rectum"},{"issue":"5","key":"10.1016\/j.jaad.2016.06.014_bib63","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/BF02235571","article-title":"Severe steroid-unresponsive ulcerative colitis","volume":"43","author":"Pinna-Pintor","year":"2000","journal-title":"Dis Colon Rectum"},{"issue":"10","key":"10.1016\/j.jaad.2016.06.014_bib64","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1007\/BF02234594","article-title":"Cyclosporin for severe ulcerative colitis does not increase the rate of perioperative complications","volume":"44","author":"Hyde","year":"2001","journal-title":"Dis Colon Rectum"},{"issue":"22","key":"10.1016\/j.jaad.2016.06.014_bib65","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1016\/j.jacc.2014.07.944","article-title":"2014 ACC\/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"64","author":"Fleisher","year":"2014","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962216303917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962216303917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:39:42Z","timestamp":1759271982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962216303917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0190962216303917"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2016.06.014","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From the Medical Board of the National Psoriasis Foundation: Perioperative management of systemic immunomodulatory agents in patients with psoriasis and psoriatic arthritis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2016.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}